ENAapplication/xmlftp.sra.ebi.ac.uk/vol1/fastq/ERR586/003/ERR5862233/ERR5862233_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/008/ERR5862218/ERR5862218_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/004/ERR5862204/ERR5862204_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/004/ERR5862214/ERR5862214_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/004/ERR5862244/ERR5862244_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/006/ERR5862196/ERR5862196_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/002/ERR5862242/ERR5862242_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/000/ERR5862240/ERR5862240_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/008/ERR5862188/ERR5862188_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/002/ERR5862252/ERR5862252_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/009/ERR5862209/ERR5862209_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/007/ERR5862197/ERR5862197_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/004/ERR5862224/ERR5862224_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/002/ERR5862222/ERR5862222_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/003/ERR5862193/ERR5862193_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/007/ERR5862247/ERR5862247_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/008/ERR5862218/ERR5862218_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/002/ERR5862252/ERR5862252_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/004/ERR5862194/ERR5862194_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/008/ERR5862188/ERR5862188_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/003/ERR5862233/ERR5862233_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/000/ERR5862190/ERR5862190_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/003/ERR5862243/ERR5862243_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/004/ERR5862214/ERR5862214_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/002/ERR5862222/ERR5862222_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/009/ERR5862219/ERR5862219_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/005/ERR5862215/ERR5862215_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/006/ERR5862236/ERR5862236_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/002/ERR5862232/ERR5862232_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/003/ERR5862213/ERR5862213_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/009/ERR5862209/ERR5862209_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/000/ERR5862190/ERR5862190_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/005/ERR5862185/ERR5862185_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/003/ERR5862243/ERR5862243_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/005/ERR5862185/ERR5862185_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/007/ERR5862197/ERR5862197_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/007/ERR5862187/ERR5862187_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/004/ERR5862224/ERR5862224_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/003/ERR5862253/ERR5862253_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/001/ERR5862251/ERR5862251_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/002/ERR5862242/ERR5862242_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/000/ERR5862240/ERR5862240_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/005/ERR5862215/ERR5862215_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/003/ERR5862213/ERR5862213_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/004/ERR5862194/ERR5862194_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR593/002/ERR5931002/ERR5931002.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/009/ERR5862219/ERR5862219_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/004/ERR5862204/ERR5862204_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/006/ERR5862236/ERR5862236_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/003/ERR5862253/ERR5862253_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/007/ERR5862187/ERR5862187_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/001/ERR5862251/ERR5862251_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/007/ERR5862247/ERR5862247_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/003/ERR5862193/ERR5862193_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/004/ERR5862244/ERR5862244_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/006/ERR5862196/ERR5862196_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/ERR586/002/ERR5862232/ERR5862232_2.fastq.gzprimaryOK200GenomicsUZHhttps://www.ebi.ac.uk/ena/browser/view/PRJEB44616Healthcare-associated outbreaks of vancomycin-resistant Enterococcus faecium (VREfm) are a worldwide problem with increasing prevalence. The genomic plasticity of this hospital-adapted pathogen contributes to its efficient spread despite infection control measures. Here, we aimed to identify the genomic and phenotypic determinants of healthcare-associated transmission of VREfm. We assessed the VREfm transmission networks at the tertiary-care University Hospital of Zurich (USZ) between October 2014 and February 2018 and investigated microevolutionary dynamics of this pathogen. We performed whole-genome sequencing for the 69 VREfm isolates collected during this timeframe and assessed the population structure and variability of the vancomycin resistance transposon. Phylogenomic analysis allowed us to reconstruct transmission networks and to unveil external or indirect transmission networks, not detectable by traditional surveillance. Notably, it unveiled a persistent clone, sampled 31 times over a 29-month period. Exploring the evolutionary dynamics of this clone and characterizing the phenotypic consequences revealed the spread of a variant with decreased daptomycin susceptibility and the acquired ability to utilize N acetyl galactosamine (GalNAc), one of the primary constituents of the human gut mucins. This nutrient utilization advantage was conferred by a novel plasmid, termed pELF_USZ, which exhibited a linear topology. This plasmid, which was harbored by two distinct clones, was transferable by conjugation. Overall, this work provides an example of the potential of the integration of epidemiological, functional genomic and evolutionary perspectives to understand adaptation strategies contributing to the successful spread of VREfm.ENA12).1(29, 11:18, insensitive, 18R, Vancomicina Abbott, 5-m][10, Decahydrate, Vancomycin-ratiopharm, vancomicin, nutrients., 15-dichloro-2, 6).2(14, 38a-tetradecahydro-7, 22H-23, 22S, 17).1(8, 16:31, vancomycin, 39)]pentaconta-3, 8(48), 39-pentaoxo-1H, 11, 2.6Sp)-O(4.2), 14, Vanco-saar, 16, 18, 43-pentaazaoctacyclo[26.14.2.2(3, O(4.6):C(3.5), Vancomicina Norman, 11R, 23S, 2, AB-Vancomycin, 3, VANCOMYCIN, 4, 5, 6, 7, 30aS, 9, 6-trideoxy-3-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyloxy]-5, 25).0(34, Vancomycin Hydrochloride, vancomicina, 22, 23, 44-pentaoxo-7, 24, 25, 26, 19-dichloro-2, 27, 28, Vancomycin, 36R, 33).0(10, (2.2Sp, C(3.4):C(5.4), 30, Vancomycin Lilly, 32, 2R, 34, 6-trideoxy-3-C-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyloxy]-3-(carbamoylmethyl)-10, 35, 36, 37, 38, Vancomycin Phosphate (1:2), Vancomycin Hexal, (1S, 6-trideoxy-3-C-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyl]oxy}phenyl)glycyl-D-2-(4-hydroxyphenyl)glycyl-3-chloro-(R)-beta-hydroxy-L-tyrosyl-L-2-(3, 25R, 35-di(metheno)[1, 16]benzoxadiazacyclotetracosine-26-carboxylic acid, Vancomicina Chiesi, 41, 38aR)-44-[2-O-(3-amino-2, 42, 46, nutrient, Vancocin, Diatracin, Vanco Azupharma, 26S, 9]oxadiazacyclohexadecino[4, Streptococcus faecium, Vancomycin Sulfate, 13-dioxa-21, VANCO-cell, (3S, Vancomycine Dakota, Hydrochloride, Vancomicina Combino Phar, Vancocin HCl, Vancocine, vancomycine, 32-pentahydroxy-6-(N-methyl-D-leucyl)-2, C(2.7)-tricyclo[N-methyl-D-leucyl-3-chloro-(R)-beta-hydroxy-D-tyrosyl-L-asparaginyl-D-2-(4-{[2-O-(3-amino-2, resistant, 28R, 3.5Sa, 36-(epiminomethano)-8, 5-dihydroxyphenyl)glycine], 37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20, 6R, vancomycinum, 40S)-22-(2-amino-2-oxoethyl)-48-[2-O-(3-amino-2, 29(45), 21-dietheno-13, 49-pentadecaene-40-carboxylic acid, 7R, Sulfategenome, Surveillance, Epidemiology / Surveillance, surveillance., Genome, Genomic0.00.00.00.00.0falseGenomic surveillance of VREfmGenomic surveillance of vancomycin-resistant Enterococcus faecium reveals local spread of a linear plasmid conferring a nutrient utilization advantage2021-05-112021-04-30PRJEB446161352